Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk. Read more about Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.
Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60. Read more about Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.
Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience. Read more about Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. Read more about Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas. Read more about 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma. Read more about Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
Salvage therapy outcomes for atypical meningioma. Read more about Salvage therapy outcomes for atypical meningioma.
Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma. Read more about Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
Tumor treating fields: a new approach to glioblastoma therapy. Read more about Tumor treating fields: a new approach to glioblastoma therapy.
Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis. Read more about Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.
